BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

964 related articles for article (PubMed ID: 34900028)

  • 1. Early Prediction of Disease Progression in Patients with Severe COVID-19 Using C-Reactive Protein to Albumin Ratio.
    Li Y; Li H; Song C; Lu R; Zhao Y; Lin F; Han D; Chen L; Pan P; Dai M
    Dis Markers; 2021; 2021():6304189. PubMed ID: 34900028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of clinical parameters in predicting the severity of COVID-19.
    Shang W; Dong J; Ren Y; Tian M; Li W; Hu J; Li Y
    J Med Virol; 2020 Oct; 92(10):2188-2192. PubMed ID: 32436996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized combination of circulating biomarkers as predictors of prognosis in AECOPD patients complicated with Heart Failure.
    Yao C; Wang L; Shi F; Chen R; Li B; Liu W; Feng M; Li S
    Int J Med Sci; 2021; 18(7):1592-1599. PubMed ID: 33746575
    [No Abstract]   [Full Text] [Related]  

  • 4. IL-6-based mortality risk model for hospitalized patients with COVID-19.
    Laguna-Goya R; Utrero-Rico A; Talayero P; Lasa-Lazaro M; Ramirez-Fernandez A; Naranjo L; Segura-Tudela A; Cabrera-Marante O; Rodriguez de Frias E; Garcia-Garcia R; Fernández-Ruiz M; Aguado JM; Martinez-Lopez J; Lopez EA; Catalan M; Serrano A; Paz-Artal E
    J Allergy Clin Immunol; 2020 Oct; 146(4):799-807.e9. PubMed ID: 32710975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort.
    Cheng B; Hu J; Zuo X; Chen J; Li X; Chen Y; Yang G; Shi X; Deng A
    Clin Microbiol Infect; 2020 Oct; 26(10):1400-1405. PubMed ID: 32622952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study.
    Pan F; Yang L; Li Y; Liang B; Li L; Ye T; Li L; Liu D; Gui S; Hu Y; Zheng C
    Int J Med Sci; 2020; 17(9):1281-1292. PubMed ID: 32547323
    [No Abstract]   [Full Text] [Related]  

  • 7. A Retrospective Study of the C-Reactive Protein to Lymphocyte Ratio and Disease Severity in 108 Patients with Early COVID-19 Pneumonia from January to March 2020 in Wuhan, China.
    Yang M; Chen X; Xu Y
    Med Sci Monit; 2020 Sep; 26():e926393. PubMed ID: 32914767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences of inflammatory and non-inflammatory indicators in Coronavirus disease-19 (COVID-19) with different severity.
    Wang M; Zhu Q; Fu J; Liu L; Xiao M; Du Y
    Infect Genet Evol; 2020 Nov; 85():104511. PubMed ID: 32858231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A meta-analysis of SARS-CoV-2 patients identifies the combinatorial significance of D-dimer, C-reactive protein, lymphocyte, and neutrophil values as a predictor of disease severity.
    Singh K; Mittal S; Gollapudi S; Butzmann A; Kumar J; Ohgami RS
    Int J Lab Hematol; 2021 Apr; 43(2):324-328. PubMed ID: 33010111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Predictive Value of Preoperative High-Sensitive C-Reactive Protein/Albumin Ratio in Systemic Inflammatory Response Syndrome After Percutaneous Nephrolithotomy.
    Xu H; Hu L; Wei X; Niu J; Gao Y; He J; Hou J
    J Endourol; 2019 Jan; 33(1):1-8. PubMed ID: 30430854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does C reactive protein/Albumin ratio have prognostic value in patients with COVID-19.
    Kalabin A; Mani VR; Valdivieso SC; Donaldson B
    J Infect Dev Ctries; 2021 Aug; 15(8):1086-1093. PubMed ID: 34516415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study.
    Lorè NI; De Lorenzo R; Rancoita PMV; Cugnata F; Agresti A; Benedetti F; Bianchi ME; Bonini C; Capobianco A; Conte C; Corti A; Furlan R; Mantegani P; Maugeri N; Sciorati C; Saliu F; Silvestri L; Tresoldi C; ; Ciceri F; Rovere-Querini P; Di Serio C; Cirillo DM; Manfredi AA
    Mol Med; 2021 Oct; 27(1):129. PubMed ID: 34663207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel serological biomarkers for inflammation in predicting disease severity in patients with COVID-19.
    Xue G; Gan X; Wu Z; Xie D; Xiong Y; Hua L; Zhou B; Zhou N; Xiang J; Li J
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107065. PubMed ID: 33045571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Inflammation-Based Stage (I Stage) Predicts Overall Survival of Patients with Nasopharyngeal Carcinoma.
    Li JP; Chen SL; Liu XM; He X; Xing S; Liu YJ; Lin YH; Liu WL
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early.
    Tan C; Huang Y; Shi F; Tan K; Ma Q; Chen Y; Jiang X; Li X
    J Med Virol; 2020 Jul; 92(7):856-862. PubMed ID: 32281668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count.
    Bi X; Su Z; Yan H; Du J; Wang J; Chen L; Peng M; Chen S; Shen B; Li J
    Platelets; 2020 Jul; 31(5):674-679. PubMed ID: 32367765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil-to-lymphocyte ratio, a critical predictor for assessment of disease severity in patients with COVID-19.
    Liu L; Zheng Y; Cai L; Wu W; Tang S; Ding Y; Liu W; Kou G; Xiong Z; Wang S; Zheng S
    Int J Lab Hematol; 2021 Apr; 43(2):329-335. PubMed ID: 33099889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic utility of C-reactive protein to albumin ratio as an early warning sign in hospitalized severe COVID-19 patients.
    Karakoyun I; Colak A; Turken M; Altin Z; Arslan FD; Iyilikci V; Yilmaz N; Kose S
    Int Immunopharmacol; 2021 Feb; 91():107285. PubMed ID: 33348293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Retrospective analysis of serum C-reactive protein/albumin ratio for the prognosis of the adult patients with sepsis].
    Sun R; Sun X; Yang H; Liu Q
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 May; 28(5):413-7. PubMed ID: 29920034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of the neutrophil-to-lymphocyte ratio and C-reactive protein level for coronavirus disease 2019 (COVID-19).
    Yufei Y; Mingli L; Xuejiao L; Xuemei D; Yiming J; Qin Q; Hui S; Jie G
    Scand J Clin Lab Invest; 2020 Nov; 80(7):536-540. PubMed ID: 32804580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.